Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0146 Transporter Info | ||||
Gene Name | SLC22A23 | ||||
Transporter Name | Solute carrier family 22 member 23 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Bladder cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC22A23 in bladder cancer | [ 1 ] | |||
Location |
TSS1500 (cg01585293) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.45E+00 | Statistic Test | p-value: 1.58E-04; Z-score: -4.17E+00 | ||
Methylation in Case |
1.04E-01 (Median) | Methylation in Control | 1.51E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC22A23 in bladder cancer | [ 1 ] | |||
Location |
TSS1500 (cg04883742) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.50E+00 | Statistic Test | p-value: 7.38E-03; Z-score: -2.19E+00 | ||
Methylation in Case |
2.26E-02 (Median) | Methylation in Control | 3.40E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC22A23 in bladder cancer | [ 1 ] | |||
Location |
1stExon (cg06662991) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.30E+00 | Statistic Test | p-value: 4.62E-02; Z-score: -1.56E+00 | ||
Methylation in Case |
9.70E-02 (Median) | Methylation in Control | 1.27E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC22A23 in bladder cancer | [ 1 ] | |||
Location |
Body (cg10091752) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.72E+00 | Statistic Test | p-value: 1.99E-10; Z-score: -8.82E+00 | ||
Methylation in Case |
1.58E-01 (Median) | Methylation in Control | 4.32E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC22A23 in bladder cancer | [ 1 ] | |||
Location |
Body (cg13318241) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.27E+00 | Statistic Test | p-value: 4.96E-10; Z-score: -8.36E+00 | ||
Methylation in Case |
2.81E-01 (Median) | Methylation in Control | 6.39E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC22A23 in bladder cancer | [ 1 ] | |||
Location |
Body (cg16984553) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.34E+00 | Statistic Test | p-value: 1.16E-03; Z-score: -2.95E+00 | ||
Methylation in Case |
6.45E-02 (Median) | Methylation in Control | 8.68E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC22A23 in bladder cancer | [ 1 ] | |||
Location |
Body (cg01163597) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.30E+00 | Statistic Test | p-value: 1.94E-03; Z-score: -2.86E+00 | ||
Methylation in Case |
9.72E-02 (Median) | Methylation in Control | 1.27E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC22A23 in bladder cancer | [ 1 ] | |||
Location |
Body (cg15032604) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 3.34E-02; Z-score: -1.39E+00 | ||
Methylation in Case |
8.23E-01 (Median) | Methylation in Control | 8.36E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC22A23 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg11713788) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.21E+00 | Statistic Test | p-value: 2.14E-17; Z-score: -2.06E+00 | ||
Methylation in Case |
1.81E-01 (Median) | Methylation in Control | 4.01E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC22A23 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg05989628) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.40E+00 | Statistic Test | p-value: 8.83E-07; Z-score: -1.02E+00 | ||
Methylation in Case |
4.40E-02 (Median) | Methylation in Control | 6.17E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC22A23 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg14527280) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.41E+00 | Statistic Test | p-value: 4.47E-04; Z-score: -6.06E-01 | ||
Methylation in Case |
6.87E-02 (Median) | Methylation in Control | 9.67E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC22A23 in breast cancer | [ 2 ] | |||
Location |
Body (cg15032604) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 3.88E-07; Z-score: -1.24E+00 | ||
Methylation in Case |
8.17E-01 (Median) | Methylation in Control | 8.63E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC22A23 in breast cancer | [ 2 ] | |||
Location |
Body (cg01163597) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 2.16E-03; Z-score: 9.14E-01 | ||
Methylation in Case |
1.46E-01 (Median) | Methylation in Control | 1.26E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC22A23 in breast cancer | [ 2 ] | |||
Location |
Body (cg16984553) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 1.07E-02; Z-score: 3.19E-01 | ||
Methylation in Case |
7.82E-02 (Median) | Methylation in Control | 7.11E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC22A23 in breast cancer | [ 2 ] | |||
Location |
Body (cg10091752) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.16E+00 | Statistic Test | p-value: 1.54E-02; Z-score: -1.22E+00 | ||
Methylation in Case |
3.69E-01 (Median) | Methylation in Control | 4.27E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC22A23 in breast cancer | [ 2 ] | |||
Location |
Body (cg13318241) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 1.61E-02; Z-score: -8.97E-01 | ||
Methylation in Case |
6.09E-01 (Median) | Methylation in Control | 6.53E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC22A23 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS1500 (cg01585293) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.34E+00 | Statistic Test | p-value: 1.67E-04; Z-score: 1.25E+00 | ||
Methylation in Case |
1.00E-01 (Median) | Methylation in Control | 7.49E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC22A23 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS1500 (cg14527280) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 2.97E-02; Z-score: 1.05E+00 | ||
Methylation in Case |
4.28E-02 (Median) | Methylation in Control | 3.65E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC22A23 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
1stExon (cg04086786) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 1.55E-05; Z-score: 1.11E+00 | ||
Methylation in Case |
3.25E-02 (Median) | Methylation in Control | 2.91E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC22A23 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
1stExon (cg06662991) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 9.50E-03; Z-score: 4.89E-01 | ||
Methylation in Case |
4.61E-02 (Median) | Methylation in Control | 4.16E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC22A23 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg01163597) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.36E+00 | Statistic Test | p-value: 8.97E-05; Z-score: 1.12E+00 | ||
Methylation in Case |
1.04E-01 (Median) | Methylation in Control | 7.63E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC22A23 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg16984553) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.32E+00 | Statistic Test | p-value: 2.83E-03; Z-score: 8.99E-01 | ||
Methylation in Case |
4.66E-02 (Median) | Methylation in Control | 3.54E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC22A23 in colon adenocarcinoma | [ 4 ] | |||
Location |
TSS1500 (cg06895831) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 4.61E-04; Z-score: -1.59E+00 | ||
Methylation in Case |
4.99E-01 (Median) | Methylation in Control | 5.98E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC22A23 in colon adenocarcinoma | [ 4 ] | |||
Location |
1stExon (cg17263061) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.68E+00 | Statistic Test | p-value: 2.95E-05; Z-score: 4.30E+00 | ||
Methylation in Case |
3.77E-01 (Median) | Methylation in Control | 1.03E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC22A23 in colon adenocarcinoma | [ 4 ] | |||
Location |
Body (cg22792910) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.39E+00 | Statistic Test | p-value: 9.64E-06; Z-score: -1.68E+00 | ||
Methylation in Case |
2.95E-01 (Median) | Methylation in Control | 4.10E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC22A23 in colon adenocarcinoma | [ 4 ] | |||
Location |
Body (cg04204452) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.19E+00 | Statistic Test | p-value: 4.72E-05; Z-score: -2.74E+00 | ||
Methylation in Case |
6.43E-01 (Median) | Methylation in Control | 7.63E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC22A23 in colon adenocarcinoma | [ 4 ] | |||
Location |
Body (cg11287443) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 4.32E-03; Z-score: -9.22E-01 | ||
Methylation in Case |
7.79E-01 (Median) | Methylation in Control | 8.05E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC22A23 in colon adenocarcinoma | [ 4 ] | |||
Location |
3'UTR (cg17442852) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.44E-03; Z-score: -2.16E+00 | ||
Methylation in Case |
7.54E-01 (Median) | Methylation in Control | 8.03E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC22A23 in colorectal cancer | [ 5 ] | |||
Location |
TSS1500 (cg01585293) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.34E+00 | Statistic Test | p-value: 7.47E-10; Z-score: -1.79E+00 | ||
Methylation in Case |
1.12E-01 (Median) | Methylation in Control | 1.49E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC22A23 in colorectal cancer | [ 5 ] | |||
Location |
TSS1500 (cg14527280) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.15E+00 | Statistic Test | p-value: 2.96E-02; Z-score: -6.73E-01 | ||
Methylation in Case |
7.17E-02 (Median) | Methylation in Control | 8.25E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC22A23 in colorectal cancer | [ 5 ] | |||
Location |
TSS1500 (cg04883742) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 3.06E-02; Z-score: 6.11E-02 | ||
Methylation in Case |
1.42E-02 (Median) | Methylation in Control | 1.39E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC22A23 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg16984553) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.22E+00 | Statistic Test | p-value: 1.25E-03; Z-score: -9.32E-01 | ||
Methylation in Case |
1.08E-01 (Median) | Methylation in Control | 1.32E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC22A23 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg01163597) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 3.00E-02; Z-score: -7.01E-01 | ||
Methylation in Case |
1.71E-01 (Median) | Methylation in Control | 1.93E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC22A23 in HIV infection | [ 6 ] | |||
Location |
TSS1500 (cg14527280) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.36E+00 | Statistic Test | p-value: 2.22E-05; Z-score: 1.34E+00 | ||
Methylation in Case |
5.24E-02 (Median) | Methylation in Control | 3.85E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC22A23 in HIV infection | [ 6 ] | |||
Location |
TSS1500 (cg01585293) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 9.34E-05; Z-score: 1.17E+00 | ||
Methylation in Case |
1.08E-01 (Median) | Methylation in Control | 8.86E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC22A23 in HIV infection | [ 6 ] | |||
Location |
1stExon (cg04086786) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 6.05E-03; Z-score: 4.86E-01 | ||
Methylation in Case |
4.42E-02 (Median) | Methylation in Control | 3.94E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC22A23 in HIV infection | [ 6 ] | |||
Location |
Body (cg01163597) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.40E+00 | Statistic Test | p-value: 1.80E-06; Z-score: 2.07E+00 | ||
Methylation in Case |
1.70E-01 (Median) | Methylation in Control | 1.22E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC22A23 in HIV infection | [ 6 ] | |||
Location |
Body (cg16984553) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.48E+00 | Statistic Test | p-value: 3.48E-05; Z-score: 1.52E+00 | ||
Methylation in Case |
9.05E-02 (Median) | Methylation in Control | 6.11E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC22A23 in HIV infection | [ 6 ] | |||
Location |
Body (cg15032604) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 6.75E-03; Z-score: -8.10E-01 | ||
Methylation in Case |
8.66E-01 (Median) | Methylation in Control | 8.88E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC22A23 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg01585293) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.21E+00 | Statistic Test | p-value: 6.38E-03; Z-score: 2.62E+00 | ||
Methylation in Case |
1.41E-01 (Median) | Methylation in Control | 1.16E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC22A23 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg14527280) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.32E+00 | Statistic Test | p-value: 1.31E-02; Z-score: 2.20E+00 | ||
Methylation in Case |
9.24E-02 (Median) | Methylation in Control | 7.01E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC22A23 in lung adenocarcinoma | [ 7 ] | |||
Location |
1stExon (cg06662991) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.30E+00 | Statistic Test | p-value: 2.41E-02; Z-score: 3.31E+00 | ||
Methylation in Case |
1.39E-01 (Median) | Methylation in Control | 1.07E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC22A23 in lung adenocarcinoma | [ 7 ] | |||
Location |
Body (cg01163597) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 2.16E-02; Z-score: 2.27E+00 | ||
Methylation in Case |
2.03E-01 (Median) | Methylation in Control | 1.66E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC22A23 in lung adenocarcinoma | [ 7 ] | |||
Location |
Body (cg16984553) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.33E+00 | Statistic Test | p-value: 4.32E-02; Z-score: 3.13E+00 | ||
Methylation in Case |
1.39E-01 (Median) | Methylation in Control | 1.05E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC22A23 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
TSS1500 (cg22117918) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.61E+00 | Statistic Test | p-value: 5.32E-14; Z-score: -2.04E+00 | ||
Methylation in Case |
1.97E-01 (Median) | Methylation in Control | 3.17E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC22A23 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
1stExon (cg19791003) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 2.23E-04; Z-score: 3.58E-01 | ||
Methylation in Case |
4.46E-02 (Median) | Methylation in Control | 4.16E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC22A23 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg15618336) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.25E+00 | Statistic Test | p-value: 1.25E-16; Z-score: -2.79E+00 | ||
Methylation in Case |
6.90E-01 (Median) | Methylation in Control | 8.64E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC22A23 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg12228245) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.36E-05; Z-score: -7.12E-02 | ||
Methylation in Case |
7.35E-02 (Median) | Methylation in Control | 7.50E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC22A23 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg21995147) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 2.28E-03; Z-score: 8.84E-01 | ||
Methylation in Case |
8.85E-01 (Median) | Methylation in Control | 8.13E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC22A23 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg07560932) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 4.43E-03; Z-score: 5.59E-01 | ||
Methylation in Case |
8.87E-01 (Median) | Methylation in Control | 8.69E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC22A23 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg18984165) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 4.68E-03; Z-score: -1.20E-01 | ||
Methylation in Case |
7.94E-01 (Median) | Methylation in Control | 7.99E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC22A23 in systemic lupus erythematosus | [ 9 ] | |||
Location |
TSS1500 (cg05989628) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 2.98E-02; Z-score: -1.25E-01 | ||
Methylation in Case |
5.54E-02 (Median) | Methylation in Control | 5.72E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC22A23 in systemic lupus erythematosus | [ 9 ] | |||
Location |
Body (cg13318241) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 3.22E-02; Z-score: 2.27E-01 | ||
Methylation in Case |
7.12E-01 (Median) | Methylation in Control | 6.76E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC22A23 in atypical teratoid rhabdoid tumor | [ 10 ] | |||
Location |
1stExon (cg04086786) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.99E+00 | Statistic Test | p-value: 6.73E-25; Z-score: 6.03E+00 | ||
Methylation in Case |
5.00E-01 (Median) | Methylation in Control | 1.68E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC22A23 in atypical teratoid rhabdoid tumor | [ 10 ] | |||
Location |
1stExon (cg06662991) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.38E+00 | Statistic Test | p-value: 4.70E-23; Z-score: -3.19E+00 | ||
Methylation in Case |
5.75E-01 (Median) | Methylation in Control | 7.93E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC22A23 in atypical teratoid rhabdoid tumor | [ 10 ] | |||
Location |
Body (cg01163597) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.11E+00 | Statistic Test | p-value: 5.05E-05; Z-score: -9.45E-01 | ||
Methylation in Case |
6.79E-01 (Median) | Methylation in Control | 7.53E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC22A23 in atypical teratoid rhabdoid tumor | [ 10 ] | |||
Location |
Body (cg10091752) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.71E+00 | Statistic Test | p-value: 1.36E-02; Z-score: 7.59E-01 | ||
Methylation in Case |
4.06E-01 (Median) | Methylation in Control | 2.37E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC22A23 in atypical teratoid rhabdoid tumor | [ 10 ] | |||
Location |
Body (cg13318241) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 3.40E-02; Z-score: 4.22E-01 | ||
Methylation in Case |
8.07E-01 (Median) | Methylation in Control | 7.51E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC22A23 in hepatocellular carcinoma | [ 11 ] | |||
Location |
1stExon (cg06662991) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 5.27E-06; Z-score: -6.77E-01 | ||
Methylation in Case |
6.60E-02 (Median) | Methylation in Control | 7.30E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC22A23 in hepatocellular carcinoma | [ 11 ] | |||
Location |
1stExon (cg04086786) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 8.29E-03; Z-score: -5.71E-01 | ||
Methylation in Case |
4.48E-02 (Median) | Methylation in Control | 5.36E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC22A23 in hepatocellular carcinoma | [ 11 ] | |||
Location |
Body (cg25822376) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.50E+00 | Statistic Test | p-value: 8.49E-17; Z-score: -5.42E+00 | ||
Methylation in Case |
4.99E-01 (Median) | Methylation in Control | 7.47E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC22A23 in hepatocellular carcinoma | [ 11 ] | |||
Location |
Body (cg22631918) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 2.42E-14; Z-score: 1.25E+00 | ||
Methylation in Case |
8.87E-01 (Median) | Methylation in Control | 7.83E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC22A23 in hepatocellular carcinoma | [ 11 ] | |||
Location |
Body (cg04437194) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.24E+00 | Statistic Test | p-value: 1.15E-12; Z-score: -5.98E+00 | ||
Methylation in Case |
7.04E-01 (Median) | Methylation in Control | 8.73E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC22A23 in hepatocellular carcinoma | [ 11 ] | |||
Location |
Body (cg11201401) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 2.08E-12; Z-score: 2.80E+00 | ||
Methylation in Case |
5.76E-01 (Median) | Methylation in Control | 4.72E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC22A23 in hepatocellular carcinoma | [ 11 ] | |||
Location |
Body (cg02793415) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.25E+00 | Statistic Test | p-value: 4.17E-10; Z-score: -3.11E+00 | ||
Methylation in Case |
6.25E-01 (Median) | Methylation in Control | 7.82E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC22A23 in hepatocellular carcinoma | [ 11 ] | |||
Location |
Body (cg16984553) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.32E+00 | Statistic Test | p-value: 4.20E-08; Z-score: -1.22E+00 | ||
Methylation in Case |
5.81E-02 (Median) | Methylation in Control | 7.67E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC22A23 in hepatocellular carcinoma | [ 11 ] | |||
Location |
Body (cg13318241) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.30E+00 | Statistic Test | p-value: 2.41E-07; Z-score: -1.76E+00 | ||
Methylation in Case |
4.18E-01 (Median) | Methylation in Control | 5.44E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC22A23 in hepatocellular carcinoma | [ 11 ] | |||
Location |
Body (cg10091752) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.37E+00 | Statistic Test | p-value: 3.09E-07; Z-score: -1.74E+00 | ||
Methylation in Case |
2.20E-01 (Median) | Methylation in Control | 3.01E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC22A23 in hepatocellular carcinoma | [ 11 ] | |||
Location |
Body (cg15032604) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 8.09E-03; Z-score: -6.65E-01 | ||
Methylation in Case |
7.93E-01 (Median) | Methylation in Control | 8.16E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC22A23 in panic disorder | [ 12 ] | |||
Location |
Body (cg16984553) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -9.73E-01 | Statistic Test | p-value: 4.99E-02; Z-score: -2.07E-01 | ||
Methylation in Case |
-5.01E+00 (Median) | Methylation in Control | -4.87E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC22A23 in papillary thyroid cancer | [ 13 ] | |||
Location |
Body (cg15032604) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 2.09E-03; Z-score: -4.09E-01 | ||
Methylation in Case |
9.06E-01 (Median) | Methylation in Control | 9.16E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC22A23 in papillary thyroid cancer | [ 13 ] | |||
Location |
Body (cg13318241) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 4.13E-03; Z-score: 9.58E-01 | ||
Methylation in Case |
9.09E-01 (Median) | Methylation in Control | 8.78E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC22A23 in prostate cancer | [ 14 ] | |||
Location |
Body (cg09705798) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.68E+00 | Statistic Test | p-value: 6.03E-03; Z-score: -1.03E+01 | ||
Methylation in Case |
5.01E-01 (Median) | Methylation in Control | 8.40E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
40 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-106a directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-106a | miRNA Mature ID | miR-106a-5p | ||
miRNA Sequence |
AAAAGUGCUUACAGUGCAGGUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 2 |
miR-106b directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-106b | miRNA Mature ID | miR-106b-5p | ||
miRNA Sequence |
UAAAGUGCUGACAGUGCAGAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 3 |
miR-142 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-142 | miRNA Mature ID | miR-142-5p | ||
miRNA Sequence |
CAUAAAGUAGAAAGCACUACU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 4 |
miR-17 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-17 | miRNA Mature ID | miR-17-5p | ||
miRNA Sequence |
CAAAGUGCUUACAGUGCAGGUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 5 |
miR-20a directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-20a | miRNA Mature ID | miR-20a-5p | ||
miRNA Sequence |
UAAAGUGCUUAUAGUGCAGGUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 6 |
miR-20b directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-20b | miRNA Mature ID | miR-20b-5p | ||
miRNA Sequence |
CAAAGUGCUCAUAGUGCAGGUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 7 |
miR-302a directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-302a | miRNA Mature ID | miR-302a-3p | ||
miRNA Sequence |
UAAGUGCUUCCAUGUUUUGGUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 8 |
miR-302b directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-302b | miRNA Mature ID | miR-302b-3p | ||
miRNA Sequence |
UAAGUGCUUCCAUGUUUUAGUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 9 |
miR-302c directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-302c | miRNA Mature ID | miR-302c-3p | ||
miRNA Sequence |
UAAGUGCUUCCAUGUUUCAGUGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 10 |
miR-302d directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-302d | miRNA Mature ID | miR-302d-3p | ||
miRNA Sequence |
UAAGUGCUUCCAUGUUUGAGUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 11 |
miR-302e directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-302e | miRNA Mature ID | miR-302e | ||
miRNA Sequence |
UAAGUGCUUCCAUGCUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 12 |
miR-3127 directly targets SLC22A23 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-3127 | miRNA Mature ID | miR-3127-5p | ||
miRNA Sequence |
AUCAGGGCUUGUGGAAUGGGAAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 13 |
miR-3609 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3609 | miRNA Mature ID | miR-3609 | ||
miRNA Sequence |
CAAAGUGAUGAGUAAUACUGGCUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 14 |
miR-372 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-372 | miRNA Mature ID | miR-372-3p | ||
miRNA Sequence |
AAAGUGCUGCGACAUUUGAGCGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 15 |
miR-373 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-373 | miRNA Mature ID | miR-373-3p | ||
miRNA Sequence |
GAAGUGCUUCGAUUUUGGGGUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 16 |
miR-378a directly targets SLC22A23 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-378a | miRNA Mature ID | miR-378a-3p | ||
miRNA Sequence |
ACUGGACUUGGAGUCAGAAGGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 17 |
miR-383 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-383 | miRNA Mature ID | miR-383-5p | ||
miRNA Sequence |
AGAUCAGAAGGUGAUUGUGGCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 18 |
miR-4276 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4276 | miRNA Mature ID | miR-4276 | ||
miRNA Sequence |
CUCAGUGACUCAUGUGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 19 |
miR-4510 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4510 | miRNA Mature ID | miR-4510 | ||
miRNA Sequence |
UGAGGGAGUAGGAUGUAUGGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 20 |
miR-4772 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4772 | miRNA Mature ID | miR-4772-5p | ||
miRNA Sequence |
UGAUCAGGCAAAAUUGCAGACU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 21 |
miR-4796 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4796 | miRNA Mature ID | miR-4796-3p | ||
miRNA Sequence |
UAAAGUGGCAGAGUAUAGACAC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 22 |
miR-5094 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-5094 | miRNA Mature ID | miR-5094 | ||
miRNA Sequence |
AAUCAGUGAAUGCCUUGAACCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 23 |
miR-5190 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-5190 | miRNA Mature ID | miR-5190 | ||
miRNA Sequence |
CCAGUGACUGAGCUGGAGCCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 24 |
miR-519d directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-519d | miRNA Mature ID | miR-519d-3p | ||
miRNA Sequence |
CAAAGUGCCUCCCUUUAGAGUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 25 |
miR-520a directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-520a | miRNA Mature ID | miR-520a-3p | ||
miRNA Sequence |
AAAGUGCUUCCCUUUGGACUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 26 |
miR-520c directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-520c | miRNA Mature ID | miR-520c-3p | ||
miRNA Sequence |
AAAGUGCUUCCUUUUAGAGGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 27 |
miR-520d directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-520d | miRNA Mature ID | miR-520d-3p | ||
miRNA Sequence |
AAAGUGCUUCUCUUUGGUGGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 28 |
miR-520f directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-520f | miRNA Mature ID | miR-520f-3p | ||
miRNA Sequence |
AAGUGCUUCCUUUUAGAGGGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 29 |
miR-526b directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-526b | miRNA Mature ID | miR-526b-3p | ||
miRNA Sequence |
GAAAGUGCUUCCUUUUAGAGGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 30 |
miR-548ah directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-548ah | miRNA Mature ID | miR-548ah-5p | ||
miRNA Sequence |
AAAAGUGAUUGCAGUGUUUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 31 |
miR-5590 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-5590 | miRNA Mature ID | miR-5590-3p | ||
miRNA Sequence |
AAUAAAGUUCAUGUAUGGCAA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 32 |
miR-6127 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6127 | miRNA Mature ID | miR-6127 | ||
miRNA Sequence |
UGAGGGAGUGGGUGGGAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 33 |
miR-6129 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6129 | miRNA Mature ID | miR-6129 | ||
miRNA Sequence |
UGAGGGAGUUGGGUGUAUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 34 |
miR-6130 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6130 | miRNA Mature ID | miR-6130 | ||
miRNA Sequence |
UGAGGGAGUGGAUUGUAUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 35 |
miR-6133 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6133 | miRNA Mature ID | miR-6133 | ||
miRNA Sequence |
UGAGGGAGGAGGUUGGGUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 36 |
miR-6731 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6731 | miRNA Mature ID | miR-6731-5p | ||
miRNA Sequence |
UGGGAGAGCAGGGUAUUGUGGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 37 |
miR-6760 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6760 | miRNA Mature ID | miR-6760-5p | ||
miRNA Sequence |
CAGGGAGAAGGUGGAAGUGCAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 38 |
miR-6873 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6873 | miRNA Mature ID | miR-6873-5p | ||
miRNA Sequence |
CAGAGGGAAUACAGAGGGCAAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 39 |
miR-8085 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-8085 | miRNA Mature ID | miR-8085 | ||
miRNA Sequence |
UGGGAGAGAGGACUGUGAGGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 40 |
miR-93 directly targets SLC22A23 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-93 | miRNA Mature ID | miR-93-5p | ||
miRNA Sequence |
CAAAGUGCUGUUCGUGCAGGUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.